Suppr超能文献

多疗程立体定向放射外科治疗视神经鞘脑膜瘤——一种有效的选择:单中心经验的初步结果。

Multisession radiosurgery for optic nerve sheath meningiomas--an effective option: preliminary results of a single-center experience.

机构信息

Department of Neurosurgery, Radiotherapy Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy.

出版信息

Neurosurgery. 2011 Nov;69(5):1116-22; discussion 1122-3. doi: 10.1227/NEU.0b013e31822932fe.

Abstract

BACKGROUND

Traditional treatment options for optic nerve sheath meningiomas (ONSMs) include observation, surgery, and radiotherapy, but to date none of these has become the clear treatment of choice.

OBJECTIVE

To evaluate the effectiveness and safety of multisession radiosurgery for ONSMs.

METHODS

From May 2004 to June 2008, 21 patients with ONSMs were treated by radiosurgery using the frameless CyberKnife system. Patient age ranged from 36 to 73 years (mean, 54 years). All patients were treated using multisession radiosurgery, with 5 fractions of 5 Gy each to a total dose of 25 Gy prescribed to the 75% to 85% isodose line. Patients were evaluated for tumor growth control and visual function.

RESULTS

The median pretreatment tumor volume was 2.8 mL (range, 0.3-23 mL). The mean follow-up was 30 months (range, 11-68 months). All patients tolerated treatment well, with only 1 patient in whom a mild optic neuropathy developed (which remitted after systemic steroid therapy). No other acute or late radiation-induced toxicities were observed. No patients showed ONSM progression on follow-up magnetic resonance imaging. Two patients (10%) had a partial response. No patients had worsening of visual function; visual function was stable in 65% and improved in 35% of patients.

CONCLUSION

Multisession radiosurgery for ONSMs was found to be safe and effective. The preliminary results from this study, in terms of growth control, visual function improvement, and toxicity, are quite promising. Further investigations are warranted.

摘要

背景

视神经鞘脑膜瘤(ONSM)的传统治疗选择包括观察、手术和放疗,但迄今为止,这些方法都没有成为明确的治疗选择。

目的

评估多疗程放射外科治疗 ONSM 的有效性和安全性。

方法

2004 年 5 月至 2008 年 6 月,21 例 ONSM 患者采用无框架 CyberKnife 系统行放射外科治疗。患者年龄 36 岁至 73 岁(平均年龄 54 岁)。所有患者均接受多疗程放射外科治疗,5 次分割,每次 5 Gy,总剂量为 25 Gy,处方剂量为 75%至 85%等剂量曲线。对患者进行肿瘤生长控制和视觉功能评估。

结果

中位预处理肿瘤体积为 2.8ml(范围:0.3-23ml)。平均随访时间为 30 个月(范围:11-68 个月)。所有患者均能耐受治疗,仅有 1 例患者发生轻度视神经病变(经全身类固醇治疗后缓解)。未观察到其他急性或迟发性放射性毒性。随访磁共振成像未见 ONSM 进展。2 例(10%)患者有部分缓解。无患者视觉功能恶化;65%的患者视觉功能稳定,35%的患者视觉功能改善。

结论

多疗程放射外科治疗 ONSM 是安全有效的。本研究在肿瘤控制、视力改善和毒性方面的初步结果很有前景,需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验